The federal government has tapped a local company to help defend against superbugs.
Gaithersburg’s Adaptive Phage Therapeutics Inc. has earned a $10.2 million contract with the Department of Defense to help advance PhageBank, APT’s collection of viruses that target specific pathogens and kill drug-resistant bacteria. The ultimate goal is to make its therapy for drug-resistant infections available to the U.S. military and the public, APT said Wednesday.
Image: Dr. Carl Merril, third from right, with his son Greg, CEO and co-founder of Adaptive Phage Therapeutics, and other members of the team. ADAPTIVE PHAGE THERAPEUTICS INC.
{iframe}https://www-bizjournals-com.cdn.ampproject.org/c/s/www.bizjournals.com/washington/news/2020/01/08/gaithersburg-company-lands-10-2m-dod-contract-for.amp.html{/iframe}